top of page

Clinical, Neurocognitive, and Emotional Effects of Psilocybin in Depressed Patients - Proof of Concept

About the study

NCT Trial Number

NCT03715127

The drug being studied

Psilocybin

noun_Drug_2240951.png
noun_Institution_118530.png

Sponsored by

University of Zurich|Schweizerischer Nationalfonds

noun_date_3237048.png

Trial Start Date

Mar-19

noun_capsule_138144.png

About the participants

Age seeking

18 Years to 60 Years

gender

All

noun_Mental Health_2683241.png

Primary condition of volunteers accepted

Depression

noun_square_138133.png

Accepts healthy volunteers?

No

This study explores the effects of psilocybin on mood and emotion processing in major depressive disorder

Eyes Graffiti

Locations

Switzerland
Psychiatrische Universitätsklinik Zürich Recruiting
Zürich, Switzerland, 8032

Contact: Franz X. Vollenweider, Prof, MD
+41 44 384 24 04
vollen@bli.uzh.ch

Contact: Andres C. Ort, MD
+41 44 384 27 50
ort@bli.uzh.ch

​

​

​

​

Get in contact

Find a study site convenient for you below, then email yourself the contact details and next steps

bottom of page